CVE-2017-17677

HIGHCVSS 8.8/10EPSS 1.33%

Last modified

CVE-2017-17677 is a high-severity vulnerability rated 8.8/10 on the CVSS scale. BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.. EPSS estimates a 1.33% chance of exploitation in the next 30 days.

Description

BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.

Metrics

CVSS 3.1
8.8/10

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

EPSS Probability
1.33%

67.6th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersionsUpdate
BmcRemedy Mid-Tier9.1Sp3

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2017-17677?
BMC Remedy 9.1SP3 is affected by authenticated code execution. Authenticated users that have the right to create reports can use BIRT templates to run code.
How severe is CVE-2017-17677?
CVE-2017-17677 has a CVSS score of 8.8/10 (HIGH severity). The EPSS model estimates a 1.33% probability of exploitation in the next 30 days.
How do I fix CVE-2017-17677?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2017-17677?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST